Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 42

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 42
---
                         | — |         |
| Inducement Plan       |     |                                                     |  2,292,032 |     |                                                            |     | 18.89 |     |                                                                |     | 7.53 |     |                                                                       |   |    469,200 |     |                                                                                         | — |         |
| All Equity Plans      |     |                                                     | 16,547,766 |     |                                                            |     |  6.80 |     |                                                                |     | 7.39 |     |                                                                       |   | 21,406,508 |     |                                                                                         |   | 392,429 |

(1) The Company previously maintained a 2005 Stock Plan, which terminated and under which no new awards have been or will be granted since such termination. In addition, no awards remain outstanding under such plan.

(2) Excludes PSUs.

(3) Number of shares shown assumes target performance achievement. The maximum number of shares under the PSUs is 200% of the target number of shares subject to the award.

(4) The 2010 Plan and 2010 Director Plan terminated and no new awards have been or will be granted since such terminations.

Our Compensation Committee takes a thoughtful approach to managing dilution and burn rate usage, by considering industry peer usage and market competitiveness levels in approving equity grants throughout the Company as part of our broader human capital management strategy. In determining the number of Shares that would become available under our 2020 Plan, the Compensation

| 2025 Proxy Statement |     | 32 |

TABLE OF CONTENTS

Committee considered the resulting overhang as an additional metric to measure the cumulative effect of equity compensation.

• Monitoring Equity Use . The Compensation Committee is cognizant that the Company’s equity compensation programs have a dilutive effect on our stockholders, and continuously strives to balance this concern with our need to compete for talent using practices that are prevalent in the market, including equity grants. We will continue to monitor our equity use in future years in an attempt to ensure that our burn rate is within competitive market norms.

• Compensation Consultant Input . The Compensation Committee considered share modeling recommendations provided by its third-party compensation consultant, in addition to input from Alliance Advisors.

#### Reasons for Voting for the Proposal
The 2020 Plan has been designed consistent with best corporate governance practices.

• No “Evergreen” Provision; Stockholder Approval Is Required for Additional Shares . The 2020 Plan does not contain any annual “evergreen